Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jun Wu, MD"'
Autor:
D. Ross Camidge, MD, PhD, Fabrice Barlesi, MD, PhD, Jonathan W. Goldman, MD, Daniel Morgensztern, MD, Rebecca Heist, MD, MPH, Everett Vokes, MD, Eric Angevin, MD, PhD, David S. Hong, MD, Igor I. Rybkin, MD, Minal Barve, MD, Todd M. Bauer, MD, Angelo Delmonte, MD, Martin Dunbar, DrPH, Monica Motwani, PhD, Apurvasena Parikh, PhD, Elysa Noon, PhD, Jun Wu, MD, Vincent Blot, PhD, Karen Kelly, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 1, Pp 100262- (2022)
Introduction: Telisotuzumab vedotin (Teliso-V) is an anti-c-Met–directed antibody-drug conjugate that has exhibited antitumor activity as monotherapy in NSCLC. Its potential activity combined with programmed cell death protein-1 inhibitors has not
Externí odkaz:
https://doaj.org/article/5db379369d064b09bb9b7152b523f622
Autor:
Hui-Fang Song, MD, PhD, Sheng He, MD, PhD, Shu-Hong Li, MD, MSc, Wen-Juan Yin, MD, MSc, Jun Wu, MD, MSc, Jian Guo, MD, PhD, Zheng-Bo Shao, MD, PhD, Xiao-Yan Zhai, MD, PhD, Hui Gong, MD, PhD, Li Lu, MD, PhD, Fang Wei, MD, PhD, Richard D. Weisel, MD, Jun Xie, MD, PhD, Ren-Ke Li, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 6, Pp 702-716 (2017)
Reduced regenerative capacity of aged stem cells hampers the benefits of autologous cell therapy for cardiac regeneration. This study investigated whether neuron-derived neurotrophic factor (NDNF) could rejuvenate aged human bone marrow (hBM)- multip
Externí odkaz:
https://doaj.org/article/3553705fb9874577888ad9d5f98f0db8
Autor:
Xinwei Zang Master Degree, Yu Su PhD, Wenjie Zhang Master Degree, Xiangyu Cao Master Degree, Chunyan Li PhD, Shan Lu PhD, Huiru Zhao Master Degree, Yuying Chen Master Degree, Cuiying Liang Master Degree, Jun Wu MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Venous thromboembolism is a common complication following trauma. We investigated the dynamics of plasma microparticles (MPs) levels and explored their potential as biomarkers of deep vein thromboembolism (DVT) after trauma. A total of 775 patients w
Externí odkaz:
https://doaj.org/article/ecb5ceb7f36743129e53ac7a86fe9612
Autor:
Mohamed M. Ibrahim, MD, Hysem Eldik, BS, Mahmoud M. Mohammed, B.ENG, Zi Jun Wu, MD, Timothy King, MD, PhD, Bruce Klitzman, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 4S, Pp 112-113 (2018)
Autor:
Jia-Jun Wu, MD, Po-Hsin Lee, MD, Zhe-Rong Zheng, MD, Yen-Hsiang Huang, MD, Jeng-Sen Tseng, MD, PhD, Kuo-Hsuan Hsu, MD, Tsung-Ying Yang, MD, PhD, Sung-Liang Yu, PhD, Kun-Chieh Chen, MD, PhD, Gee-Chen Chang, MD, PhD
Publikováno v:
Medicine, Vol 101, Iss 24, p e29381 (2022)
Abstract. Kirsten rat sarcoma (KRAS) mutation (KRASm) is associated with poor prognosis in non-small cell lung cancer (NSCLC) patients. We have aimed to survey NSCLC patients harboring KRASm in Taiwan, where never-smoking lung adenocarcinoma predomin
Externí odkaz:
https://doaj.org/article/a56029aa8b94409bbb6bb1f17c32aa25
Autor:
Cheng-You Jia PhD, Wei Xiang PhD, Ji-Bin Liu MD, Geng-Xi Jiang MD, Feng Sun MD, Jian-Jun Wu MD, Xiao-Li Yang PhD, Rui Xin PhD, Yi Shi PhD, Dan-Dan Zhang PhD, Wen Li PhD, Zavuga Zuberi PhD, Jie Zhang PhD, Gai-Xia Lu MD, Hui-Min Wang PhD, Pei-Yao Wang PhD, Fei Yu MD, Zhong-Wei Lv MD, Yu-Shui Ma PhD, Da Fu PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Lung cancer is listed as the most common reason for cancer-related death all over the world despite diagnostic improvements and the development of chemotherapy and targeted therapies. MicroRNAs control both physiological and pathological processes in
Externí odkaz:
https://doaj.org/article/f65e20d345904d009ececaf7b0854ec6
Autor:
Wenhua Ren MM, Jing Zhang MD, Yuying Chen MM, Meng Wen MM, Yu Su PhD, Yujing Zhao MM, Shan Lu PhD, Jun Wu MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
To evaluate variations in coagulation, fibrinolysis and endothelial marker expression in cirrhotic patients and to explore their clinical value and predictive performance in cirrhotic patients with or without portal vein thrombosis (PVT), we performe
Externí odkaz:
https://doaj.org/article/30133b54ec9741e2a1e8f8e2b4e48b59
Autor:
Yuying Cheng MD, Jian Liu PhD, Yu Su PhD, Huiru Zhao MD, Yujing Zhao MD, Meng Wen MD, Shan Lu PhD, Wenjie Zhang MD, Jun Wu MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
One common complication after joint arthroplasty is venous thromboembolism (VTE). Therefore, it is essential to measure the changes in coagulation and fibrinolysis in order to predict VTE among patients who underwent joint arthroplasty. This study ai
Externí odkaz:
https://doaj.org/article/61f212e6f1c24628804e97e65ea61594